InsidersTradesSigma
Track the Solid Biosciences Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Solid Biosciences Inc. has recorded 96 public disclosures. Market capitalisation: €776.8m. The latest transaction was reported on 7 July 2026 (Levée d'options). Among the most active insiders: SMITH IAN F. The full history is accessible without an account.
96
Insider Decl.
n/a
Thresholds
€47m
7 ops.
Buy Volume
€756,292
13 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Solid Biosciences Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$17.50.
48Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,662 of 28,586 companies
22.1
score / 100
Value12
Quality33
FCF yld-16%
Earn yld-18%
EV/EBITDA·
ROE-66%
Gross mgn43%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2026
Declarations96 total
3,440 sharesCommon StockSEC:0001193125-26-297456:0
3,441 sharesCommon StockSEC:0001193125-26-140056:0
30,031 sharesCommon StockSEC:0001193125-26-057878:0
8,125 sharesCommon StockSEC:0001193125-26-057872:0
4,861 sharesCommon StockSEC:0001193125-26-057868:0
7,187 sharesCommon StockSEC:0001193125-26-057865:0
14,687 sharesCommon StockSEC:0001193125-26-057863:0
10,937 sharesCommon StockSEC:0001193125-26-057859:0
18,894 shares@ US$6.4419100.0% of flowCommon StockSEC:0001193125-26-041523:0
48,913 shares@ US$6.4419100.0% of flowCommon StockSEC:0001193125-26-041519:0
7,205 shares@ US$6.441976.4% of flowCommon StockSEC:0001193125-26-041516:0
12,616 shares@ US$6.441968.0% of flowCommon StockSEC:0001193125-26-041511:0
12,348 shares@ US$6.4419100.0% of flowCommon StockSEC:0001193125-26-041507:0
10,905 shares@ US$6.4419100.0% of flowCommon StockSEC:0001193125-26-041506:0
79,341 sharesCommon StockSEC:0001193125-26-034080:0
54,925 sharesCommon StockSEC:0001193125-26-034076:0
15,000 sharesCommon StockSEC:0001193125-26-034072:0
169,401 sharesCommon StockSEC:0001193125-26-034087:0
54,925 sharesCommon StockSEC:0001193125-26-034085:0
58,847 sharesCommon StockSEC:0001193125-26-034083:0
389 sharesCommon StockSEC:0001193125-26-031765:0
25 of 96 declarations
Acerca de Solid Biosciences Inc.
Solid Biosciences Inc. es una empresa biofarmacéutica enfocada en el desarrollo de tratamientos para enfermedades genéticas raras, particularmente la distrofia muscular de Duchenne. La empresa cotiza en NASDAQ bajo el símbolo SLDB.